Haro Hartounian, Ph.D. is the founder of BioCentriq, a boutique Cell and Gene Therapy CDMO. He engineered the launch of BioCentriq, the only facility of its kind in Newark, NJ and led the creation of NJIT’s new Professional Master’s Degree Program in Cell and Gene Therapy Sciences. Dr. Hartounian developed an approach that enables BioCentriq to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations. He grew the organization by recruiting top-notch scientists, engineers, and professionals whose expertise and assembled a world class technical advisory board of experts who provide key strategic insights.